Acute Lymphoblastic Leukemia
📧 Sign up to get email alerts when something new happens for Acute Lymphoblastic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-06-26Clinical Trial Update: P3 Study of Umbilical Cord Blood Cells Expanded With MPCs for Transplantation in Patients With Hematologic Malignancies [Phase 3]
Phase 3 trial of umbilical cord blood cells expanded with MPCs for transplantation in hematologic malignancies has completed.
-
FDA approval · 2020-06-26FDA Approved: CYTARABINE — Original Application (Meitheal Pharmaceuticals Inc.)
FDA approval of Meitheal Pharmaceuticals' original ANDA for Cytarabine (cytarabine), a generic injectable anticancer agent.
-
FDA approval · 2020-06-24FDA Approved: ASPARLAS — Supplemental Application (Servier Pharmaceuticals LLC)
FDA approved a supplemental application for ASPARLAS (calaspargase pegol) from Servier Pharmaceuticals LLC, resulting in a labeling update. …
-
CLINICAL_TRIALS trial_result · 2020-06-23Clinical Trial Update: Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma [Phase 3]
A Phase 3 clinical trial update reports results of a risk-adapted chemotherapy approach for younger patients with newly diagnosed standard-r…
-
FDA approval · 2020-06-17FDA Approved: ICLUSIG — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for Iclusig (ponatinib hydrochloride) from Takeda Pharmaceuticals America, Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2020-06-17FDA Approved: ONCASPAR — Supplemental Application (Servier Pharmaceuticals LLC)
The FDA approved a supplemental application for ONCASPAR (pegaspargase) submitted by Servier Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2020-05-04Clinical Trial Update: Treosulfan-based Conditioning in Paediatric Patients With Haematological Malignancies [Phase 2]
Phase 2 trial update evaluating treosulfan-based conditioning in pediatric patients with hematological malignancies.
-
CLINICAL_TRIALS trial_result · 2020-04-27Clinical Trial Update: Bioelectrical Impedance Measurement for Predicting Treatment Outcome in Patients With Newly Diagnosed Acute Leukemia [NA]
A completed clinical trial evaluating bioelectrical impedance measurements to predict treatment outcomes in newly diagnosed acute leukemia p…
-
CLINICAL_TRIALS trial_result · 2020-04-21Clinical Trial Update: Donor-Derived Humoral Immunity, Hematopoietic Stem Cell Transplantation, TAR [NA]
Clinical trial update on donor-derived humoral immunity and hematopoietic stem cell transplantation completed with posted results in 2020.
-
CLINICAL_TRIALS trial_result · 2020-04-15Clinical Trial Update: Thiopurine EnhAnced Maintenance Therapy [Phase 1, Phase 2]
Phase 1/2 trial evaluating thiopurine enhanced maintenance therapy in acute lymphoblastic leukemia and lymphoblastic lymphoma has completed.
-
FDA approval · 2020-04-07FDA Approved: MERCAPTOPURINE — Supplemental Application (Nova Laboratories, Ltd)
FDA approved a supplemental application for Mercaptopurine (Purixan) submitted by Nova Laboratories, Ltd.
-
CLINICAL_TRIALS trial_result · 2020-04-07Clinical Trial Update: Treatment of High Risk Adult Acute Lymphoblastic Leukemia [Phase 4]
Phase 4 clinical trial update for high-risk adult acute lymphoblastic leukemia sponsored by PETHEMA Foundation; study completed.
-
FDA approval · 2020-03-20FDA Approved: BLINCYTO — Supplemental Application (Amgen, Inc)
The FDA approved Amgen's supplemental application for BLINCYTO (blinatumomab), expanding the drug's regulatory authorization beyond the orig…
-
CLINICAL_TRIALS trial_result · 2020-03-05Clinical Trial Update: Two Combination Chemotherapy Regimens in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia [Phase 3]
Phase 3 trial comparing two combination chemotherapy regimens in children with newly diagnosed acute lymphoblastic leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2020-03-05Clinical Trial Update: Pethema LAL-RI/2008: Treatment for Patients With Standard Risk Acute Lymphoblastic Leukemia [Phase 4]
Phase 4 trial update for standard risk acute lymphoblastic leukemia treated under the Pethema LAL-RI/2008 study.
-
CLINICAL_TRIALS trial_result · 2020-02-26Clinical Trial Update: Study of ADCT-301 in Patients With Relapsed/Refractory CD25-positive Acute Myeloid Leukemia (AML) or CD25-positive Acute Lymphoblastic Leukemia (ALL) [Phase 1]
Phase 1 trial of ADCT-301 in relapsed/refractory CD25-positive AML or CD25-positive ALL was terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-02-20Clinical Trial Update: AC220 for Children With Relapsed/Refractory ALL or AML [Phase 1]
Phase 1 clinical trial update for AC220 in children with relapsed/refractory acute lymphoblastic leukemia or acute myeloid leukemia; study c…
-
CLINICAL_TRIALS trial_result · 2020-02-19Clinical Trial Update: Bortezomib With Chemotherapy for Relapsed Pediatric Acute Lymphoblastic Leukemia (ALL) [Phase 1, Phase 2]
Phase 1/2 trial update evaluating bortezomib in combination with chemotherapy for relapsed pediatric acute lymphoblastic leukemia; study com…
-
CLINICAL_TRIALS trial_result · 2020-02-18Clinical Trial Update: INCB018424 in Patients With Advanced Hematologic Malignancies [Phase 2]
Phase 2 trial of INCB018424 (ruxolitinib) in patients with advanced hematologic malignancies. Results for diseases including AML, ALL, MDS, …
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: CART19 in Adult Patients With Minimal Residual Disease During Upfront Treatment for ALL [Phase 2]
Phase 2 trial update on CART19 therapy for adults with minimal residual disease during upfront treatment for acute lymphoblastic leukemia; s…
-
CLINICAL_TRIALS trial_result · 2020-01-31Clinical Trial Update: Nivolumab and Dasatinib in Treating Patients With Relapsed or Refractory Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia [Phase 1]
Phase 1 clinical trial investigating nivolumab and dasatinib in relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic …
-
CLINICAL_TRIALS trial_result · 2020-01-31Clinical Trial Update: Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia [Phase 2]
A Phase 2 clinical trial evaluating combination chemotherapy in newly diagnosed acute lymphoblastic leukemia in young patients.
-
FDA approval · 2020-01-30FDA Approved: METHOTREXATE — Original Application (Chartwell RX, LLC)
FDA approvedChartwell RX, LLC's methotrexate product under an Original Application, making a new generic version of methotrexate available. …
-
CLINICAL_TRIALS trial_result · 2020-01-27Clinical Trial Update: Study of CD19 Specific Chimeric Antigen Receptor Positive T Cells (CAR-T) in ALL and NHL [Phase 1, Phase 2]
Clinical trial update on CD19 CAR-T therapy for acute lymphoblastic leukemia and non-Hodgkin lymphoma (Phase 1/Phase 2).
-
CLINICAL_TRIALS trial_result · 2020-01-21Clinical Trial Update: T Cell Depletion for Recipients of HLA Haploidentical Related Donor Stem Cell Grafts [Phase 2]
A Phase 2 clinical trial evaluating T cell depletion in recipients of HLA haploidentical related donor stem cell grafts for various hematolo…